Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'RIFABUTIN' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 237 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Liu, XG; Li, RC
      Effects of repeated rifabutin administration on the pharmacokinetics of intravenous and oral ciprofloxacin in mice

      JOURNAL OF CHEMOTHERAPY
    2. Fietta, A; Morosini, M; Cascina, A
      Effects of continuous or pulsed exposure to rifabutin and sparfloxacin on the intracellular growth of Staphylococcus aureus and Mycobacterium tuberculosis

      JOURNAL OF CHEMOTHERAPY
    3. Todd, JR; Arigala, MR; Penn, RL; King, JW
      Possible clinically significant interaction of itraconazole plus rifampin

      AIDS PATIENT CARE AND STDS
    4. Burman, WJ; Jones, BE
      Treatment of HIV-related tuberculosis in the era of effective antiretroviral therapy

      AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
    5. Horsburgh, CR; Gettings, J; Alexander, LN; Lennox, JL
      Disseminated Mycobacterium avium complex disease among patients infected with human immunodeficiency virus, 1985-2000

      CLINICAL INFECTIOUS DISEASES
    6. Young, LS; Bermudez, LE
      Perspective on animal models: Chronic intracellular infections

      CLINICAL INFECTIOUS DISEASES
    7. Griffith, DE; Brown, BA; Girard, WM; Griffith, BE; Couch, LA; Wallace, RJ
      Azithromycin-containing regimens for treatment of Mycobacterium avium complex lung disease

      CLINICAL INFECTIOUS DISEASES
    8. Roos, F; Flepp, M; Figueras, G; Bodmer, T; Furrer, H
      Clinical manifestations and predictors of survival in AIDS patients with disseminated Mycobacterium avium infection

      EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
    9. Patel, GK; Anstey, AV
      Rifampicin-induced lupus erythematosus

      CLINICAL AND EXPERIMENTAL DERMATOLOGY
    10. Sirgel, F; Venter, A; Mitchison, D
      Sources of variation in studies of the early bactericidal activity of antituberculosis drugs

      Journal of antimicrobial chemotherapy
    11. Chu, DS; Zaidman, GW; Meisler, DM; Lowder, C; Jacobs, DS; Rapuano, CJ; Green, GJ
      Human immunodeficiency virus-positive patients with posterior intracornealprecipitates

      OPHTHALMOLOGY
    12. Piccolomini, R; Di Bonaventura, G; Picciani, C; Laterza, F; Vecchiet, J; Neri, M
      In vitro activity of clarithromycin against intracellular Helicobacter pylori

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    13. Cantrell, CL; Franzblau, SG; Fischer, NH
      Antimycobacterial plant terpenoids

      PLANTA MEDICA
    14. Santos, L; Medeiros, MA; Santos, S; Costa, MC; Tavares, R; Curto, MJM
      NMR studies of some rifamycins

      JOURNAL OF MOLECULAR STRUCTURE
    15. Lu, C; Li, AP
      Species comparison in P450 induction: effects of dexamethasone, omeprazole, and rifampin on P450 isoforms 1A and 3A in primary cultured hepatocytes from man, Sprague-Dawley rat, minipig, and beagle dog

      CHEMICO-BIOLOGICAL INTERACTIONS
    16. Lang-Lazdunski, L; Offredo, C; Le Pimpec-Barthes, F; Danel, C; Dujon, A; Riquet, M
      Pulmonary resection for Mycobacterium xenopi pulmonary infection

      ANNALS OF THORACIC SURGERY
    17. Mouly, S; Aymard, G; Diquet, B; Caulin, C; Bergmann, JF
      Oral ganciclovir systemic exposure is enhanced in HIV-infected patients with diarrhea and weight loss

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    18. Wallis, RS; Perkins, MD; Phillips, M; Joloba, M; Namale, A; Johnson, JL; Whalen, CC; Teixeira, L; Demchuk, B; Dietze, R; Mugerwa, RD; Eisenach, K; Ellner, JJ
      Predicting the outcome of therapy for pulmonary tuberculosis

      AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
    19. Dunne, M; Fessel, J; Kumar, P; Dickenson, G; Keiser, P; Boulos, M; Mogyros, M; White, AC; Cahn, P; O'Connor, M; Lewi, D; Green, S; Tilles, J; Hicks, C; Bissett, J; Schneider, MME; Benner, R
      A randomized, double-blind trial comparing azithromycin and clarithromycinin the treatment of disseminated Mycobacterium avium infection in patientswith human immunodeficiency virus

      CLINICAL INFECTIOUS DISEASES
    20. Griffith, DE; Brown, BA; Cegielski, P; Murphy, DT; Wallace, RJ
      Early results (at 6 months) with intermittent clarithromycin-including regimens for lung disease due to Mycobacterium avium complex

      CLINICAL INFECTIOUS DISEASES
    21. Tam, CM; Chan, SL; Kam, KM; Sim, E; Staples, D; Sole, KM; Al-Ghusein, H; Mitchison, DA
      Rifapentine and isoniazid in the continuation phase of a 6-month regimen. Interim report: no activity of isoniazid in the continuation phase

      INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
    22. Khan, MA; Singh, J; Dhillon, B
      Rifabutin-induced uveitis with inflammatory vitreous infiltrate

      EYE
    23. Chien, HP; Yu, MC; Ong, TF; Lin, TP; Luh, KT
      In vitro activity of rifabutin and rifampin against clinical isolates of Mycobacterium tuberculosis in Taiwan

      JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION
    24. Kuper, JJ; D'Aprile, M
      Drug-drug interactions of clinical significance in the treatment of patients with Mycobacterium avium complex disease

      CLINICAL PHARMACOKINETICS
    25. Sirgel, FA; Donald, PR; Odhiambo, J; Githui, W; Umapathy, KC; Paramasivan, CN; Tam, CM; Kam, KM; Lam, CW; Sole, KM; Mitchison, DA
      A multicentre study of the early bactericidal activity of anti-tuberculosis drugs

      Journal of antimicrobial chemotherapy
    26. Fichtenbaum, CJ; Zackin, R; Feinberg, J; Benson, C; Griffiths, JK
      Rifabutin but not clarithromycin prevents cryptosporidiosis in persons with advanced HIV infection

      AIDS
    27. Furrer, H; Telenti, A; Rossi, M; Ledergerber, B
      Discontinuing or withholding primary prophylaxis against Mycobacterium avium in patients on successful antiretroviral combination therapy. The Swiss HIV Cohort Study

      AIDS
    28. Bock, H; Koop, H; Lehn, N; Heep, M
      Rifabutin-based triple therapy after failure of Helicobacter pylori eradication treatment - Preliminary experience

      JOURNAL OF CLINICAL GASTROENTEROLOGY
    29. Lenaerts, AM; Chase, SE; Cynamon, MH
      Evaluation of rifalazil in a combination treatment regimen as an alternative to isoniazid-rifampin therapy in a mouse tuberculosis model

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    30. Bermudez, LE; Nash, K; Petrofsky, M; Young, LS; Inderlied, CB
      Clarithromycin-resistant Mycobacterium avium is still susceptible to treatment with clarithromycin and is virulent in mice

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    31. Cynamon, MH; Carter, JL; Shoen, CM
      Activity of ABT-773 against Mycobacterium avium complex in the beige mousemodel

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    32. Mae, T; Inaba, T; Konishi, E; Hosoe, K; Hidaka, T
      Identification of enzymes responsible for rifalazil metabolism in human liver microsomes

      XENOBIOTICA
    33. Hafeez, I; Muers, MF; Murphy, SA; Evans, EGV; Barton, RC; McWhinney, P
      Non-tuberculous mycobacterial lung infection complicated by chronic necrotising pulmonary aspergillosis

      THORAX
    34. Campbell, I; Drobniewski, F; Novelli, V; Ormerod, P; Pozniak, A
      Management of opportunist mycobacterial infections: Joint Tuberculosis Committee guidelines 1999

      THORAX
    35. Garweg, JG
      Anterior segment involvement in HIV-associated eye disease after the commencement of highly active antiretroviral therapy (HAART)

      KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE
    36. Borgaonkar, MR; MacIntosh, DG; Fardy, JM
      A meta-analysis of antimycobacterial therapy for Crohn's disease

      AMERICAN JOURNAL OF GASTROENTEROLOGY
    37. Gatti, G; De Pascalis, CR; Miletich, F; Casazza, R; Bassetti, D
      Specific high-performance liquid chromatography assay for determination ofrifabutin plasma concentration following Extrelut column extraction

      JOURNAL OF CHROMATOGRAPHY B
    38. Haslam, JL; Egodage, KL; Chen, YX; Rjewski, RA; Stella, V
      Stability of rifabutin in two extemporaneously compounded oral liquids

      AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
    39. Malouf, MA; Glanville, AR
      The spectrum of mycobacterial infection after lung transplantation

      AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
    40. Tanaka, E; Kimoto, T; Tsuyuguchi, K; Watanabe, I; Matsumoto, H; Niimi, A; Suzuki, K; Murayama, T; Amitani, R; Kuze, F
      Effect of clarithromycin regimen for Mycobacterium avium complex pulmonarydisease

      AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
    41. Temple, ME; Nahata, MC
      Rifapentine: Its role in the treatment of tuberculosis

      ANNALS OF PHARMACOTHERAPY
    42. Cohn, DL; Fisher, EJ; Peng, GT; Hodges, JS; Chesnut, J; Child, CC; Franchino, B; Gibert, CL; El-Sadr, W; Hafner, R; Korvick, J; Ropka, M; Heifets, L; Clotfelter, J; Munroe, D; Horsburgh, CR
      A prospective randomized trial of four three-drug regimens in the treatment of disseminated Mycobacterium avium complex disease in AIDS patients: Excess mortality associated with high-dose clarithromycin

      CLINICAL INFECTIOUS DISEASES
    43. Schluger, NW
      Issues in the treatment of active tuberculosis in human immunodeficiency virus-infected patients

      CLINICAL INFECTIOUS DISEASES
    44. Dube, MP; Torriani, FJ; See, D; Havlir, DV; Kemper, CA; Leedom, JM; Tilles, JG; McCutchan, JA; Sattler, FR
      Successful short-term suppression of clarithromycin-resistant Mycobacterium avium complex bacteremia in AIDS

      CLINICAL INFECTIOUS DISEASES
    45. Breda, M; Benedetti, MS; Bani, M; Pellizzoni, C; Poggesi, I; Brianceschi, G; Rocchetti, M; Dolfi, L; Sassella, D; Rimoldi, R
      Effect of rifabutin on ethambutol pharmacokinetics in healthy volunteers

      PHARMACOLOGICAL RESEARCH
    46. Keung, A; Reith, K; Eller, MG; McKenzie, KA; Cheng, L; Weir, SJ
      Enzyme induction observed in healthy volunteers after repeated administration of rifapentine and its lack of effect on steady-state rifapentine pharmacokinetics: Part I

      INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
    47. Keung, A; Eller, MG; McKenzie, KA; Weir, SJ
      Single and multiple dose pharmacokinetics of rifapentine in man: Part II

      INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
    48. Matteelli, A; Olliaro, P; Signorini, L; Cadeo, G; Scalzini, A; Bonazzi, L; Caligaris, S; Tomasoni, L; Tebaldi, A; Carosi, G
      Tolerability of twice-weekly rifabutin-isoniazid combinations versus dailyisoniazid for latent tuberculosis in HIV-infected subjects: a pilot study

      INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
    49. Verma, S; Hughes, JD; Mabey, D; Graham, EM
      Symptomatic anterior uveitis in HIV-positive patients

      INTERNATIONAL JOURNAL OF STD & AIDS
    50. Keiser, P; Nassar, N; Skiest, D; Rademacher, S; Smith, JW
      A retrospective study of the addition of ciprofloxacin to clarithromycin and ethambutol in the treatment of disseminated Mycobacterium avium complex infection

      INTERNATIONAL JOURNAL OF STD & AIDS
    51. Bainbridge, JWB; Raina, J; Shah, SM; Ainsworth, J; Pinching, AJ
      Ocular complications of intravenous cidofovir for cytomegalovirus retinitis in patients with AIDS

      EYE
    52. Schaller, UC; Michl, G; Goebel, FD; Klauss, V
      Acute hypopyon uveitis in a patient with acquired immunodeficiency syndrome treated for systemic Mycobacterium avium complex (MAC) infection with rifabutin

      OPHTHALMOLOGE
    53. Jackel, MC; Witt, O; Eber, SW; Eiffert, H; Laskawi, R
      Postoperative antibiotic therapy of cervical lymphadenitis caused by nontuberculous, atypical mycobacteria.

      LARYNGO-RHINO-OTOLOGIE
    54. Fournier, S; Burguiere, AM; Flahault, A; Vincent, V; Treilhou, MP; Eliaszewicz, M
      Effect of adding clofazimine to combined clarithromycin-ethambutol therapyfor Mycobacterium avium complex septicemia in AIDS patients

      EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
    55. Cochereau, I; Doan, S; Diraison, MC; Mousalatti, H; Guvenisik, N; Ren, L; Hoang-Xuan, T
      Uveitis in patients treated with intravenous cidofovir

      OCULAR IMMUNOLOGY AND INFLAMMATION
    56. Trujillano-Martin, I; Garcia-Sanchez, E; Fresnadillo, MJ; Garcia-Sanchez, JE; Garcia-Rodriguez, JA; Martinez, IM
      In vitro activities of five new antimicrobial agents against Brucella melitensis

      INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
    57. Marshall, JD; Abdel-Rahman, S; Johnson, K; Kauffman, RE; Kearns, GL
      Rifapentine pharmacokinetics in adolescents

      PEDIATRIC INFECTIOUS DISEASE JOURNAL
    58. Le Gars, L; Collon, T; Picard, O; Kaplan, G; Berenbaum, F
      Polyarthralgia-arthritis syndrome induced by low doses of rifabutin

      JOURNAL OF RHEUMATOLOGY
    59. Gatti, G; Di Biagio, A; De Pascalis, CR; Guerra, M; Bassetti, M; Bassetti, D
      Pharmacokinetics of rifabutin in HIV-infected patients with or without wasting syndrome

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    60. Vacher, S; Pellegrin, JL; Leblanc, F; Fourche, J; Maugein, J
      Comparative antimycobacterial activities of ofloxacin, ciprofloxacin and grepafloxacin

      Journal of antimicrobial chemotherapy
    61. Singer, J; Thorne, A; Phillips, P; Rachlis, AR; Miller, M; Gill, MJ; Smaill, FM; Schlech, WF; Senay, H; Shafran, SD
      Predictors of survival and eradication of Mycobacterium avium complex bacteremia (MAC) in AIDS patients in the Canadian Randomized MAC Treatment Trial

      AIDS
    62. Pozniak, AL; Miller, R; Ormerod, LP
      The treatment of tuberculosis in HIV-infected persons

      AIDS
    63. Hewitt, RG; Papandonatos, GD; Shelton, MJ; Hsiao, CB; Harmon, BJ; Kaczmarek, SR; Amsterdam, D
      Prevention of disseminated Mycobacterium avium complex infection with reduced dose clarithromycin in patients with advanced HIV disease

      AIDS
    64. Sundaram, V; Driver, CR; Munsiff, SS
      Tuberculosis treatment practices in the era of protease inhibitors: a provider survey

      AIDS
    65. Scharfstein, JA; Paltiel, AD; Weinstein, MC; Seage, GR; Losina, E; Craven, DE; Freedberg, KA
      The cost-effectiveness of prophylaxis for Mycobacterium avium complex in AIDS

      INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE
    66. Ong, ELC
      Prophylaxis against disseminated Mycobacterium avium complex in AIDS

      JOURNAL OF INFECTION
    67. Vernon, A; Burman, W; Benator, D; Khan, A; Bozeman, L
      Acquired rifamycin monoresistance in patients with HIV-related tuberculosis treated with once-weekly rifapentine and isoniazid

      LANCET
    68. Griffith, DE
      Risk-benefit assessment of therapies for Mycobacterium avium complex infections

      DRUG SAFETY
    69. Foulds, G; LaBoy-Goral, L; Wei, GCG; Apseloff, G
      The effect of azithromycin on the pharmacokinetics of indinavir

      JOURNAL OF CLINICAL PHARMACOLOGY
    70. Bermudez, LE; Kolonoski, P; Wu, M; Aralar, PA; Inderlied, CB; Young, LS
      Mefloquine is active in vitro and in vivo against Mycobacterium avium complex

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    71. Wichelhaus, TA; Schafer, V; Brade, V; Boddinghaus, B
      Molecular characterization of rpoB mutations conferring cross-resistance to rifamycins on methicillin-resistant Staphylococcus aureus

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    72. Lenaerts, AMJA; Chase, SE; Chmielewski, AJ; Cynamon, MH
      Evaluation of rifapentine in long-term treatment regimens for tuberculosisin mice

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    73. Mayaud, C; Cadranel, J
      Tuberculosis in AIDS: past or new problems?

      THORAX
    74. Hillebrand-Haverkort, ME; Kolk, AHJ; Kox, LFF; Ten Velden, JJAM; Ten Veen, JH
      Generalized mycobacterium genavense infection in HIV-infected patients: Detection of the mycobacterium in hospital tap water

      SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES
    75. Sintchenko, V; Chew, WK; Jelfs, PJ; Gilbert, GL
      Mutations in rpoB gene and rifabutin susceptibility of multidrug-resistantMycobacterium tuberculosis strains isolated in Australia

      PATHOLOGY
    76. Witt, O; Jackel, M; Eiffert, H; Laskawi, R; Eber, S
      Management of atypical mycobacterial lymphadenitis after incomplete surgical excision

      MONATSSCHRIFT KINDERHEILKUNDE
    77. Van Scoy, RE; Wilkowske, CJ
      Antimycobacterial therapy

      MAYO CLINIC PROCEEDINGS
    78. Guex-Crosier, Y
      Effect of highly active antiretroviral therapy (HAART) on cytomegalovirus retinitis

      KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE
    79. Reinach, B; de Sousa, G; Dostert, P; Ings, R; Gugenheim, J; Rahmani, R
      Comparative effects of rifabutin and rifampicin on cytochromes P450 and UDP-glucuronosyl-transferases expression in fresh and cryopreserved human hepatocytes

      CHEMICO-BIOLOGICAL INTERACTIONS
    80. Ambati, J; Wynne, KB; Angerame, MC; Robinson, MR
      Anterior uveitis associated with intravenous cidofovir use in patients with cytomegalovirus retinitis

      BRITISH JOURNAL OF OPHTHALMOLOGY
    81. Chiodini, RJ
      Antimicrobial agents and Crohn's disease: do they have a therapeutic role?

      ITALIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
    82. Matteelli, A; Signorini, L; Tebaldi, A; Bombana, E; Chatel, G; Pinsi, G
      Long term treatment with clarithromycin for cryptosporidiosis and emergence of drug resistant disseminated infection due to Mycobacterium avium: Casereport

      JOURNAL OF CHEMOTHERAPY
    83. OBRIEN RJ; VERNON AA
      NEW TUBERCULOSIS DRUG DEVELOPMENT - HOW CAN WE DO BETTER

      American journal of respiratory and critical care medicine
    84. RIDZON R; WHITNEY CC; MCKENNA MT; TAYLOR JP; ASHKAR SH; NITTA AT; HARVEY SM; VALWAY S; WOODLEY C; COOKSEY R; ONORATO IM
      RISK-FACTORS FOR RIFAMPIN MONO-RESISTANT TUBERCULOSIS

      American journal of respiratory and critical care medicine
    85. LOMAESTRO BM; PIATEK MA
      UPDATE ON DRUG-INTERACTIONS WITH AZOLE ANTIFUNGAL AGENTS

      The Annals of pharmacotherapy
    86. SHAFRAN SD
      EDITORIAL RESPONSE - CLARITHROMYCIN PROPHYLAXIS FOR DISSEMINATED MYCOBACTERIUM-AVIUM COMPLEX INFECTION - EFFICACY AND ACQUIRED-RESISTANCE

      Clinical infectious diseases
    87. SEPKOWITZ KA
      EFFECT OF PROPHYLAXIS ON THE CLINICAL MANIFESTATIONS OF AIDS-RELATED OPPORTUNISTIC INFECTIONS

      Clinical infectious diseases
    88. OLDFIELD EC; FESSEL WJ; DUNNE MW; DICKINSON G; WALLACE MR; BYRNE W; CHUNG R; WAGNER KF; PAPARELLO SF; CRAIG DB; MELCHER G; ZAJDOWICZ M; WILLIAMS RF; KELLY JW; ZELASKY M; HEIFETS LB; BERMAN JD
      ONCE WEEKLY AZITHROMYCIN THERAPY FOR PREVENTION OF MYCOBACTERIUM-AVIUM COMPLEX INFECTION IN PATIENTS WITH AIDS - A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED MULTICENTER TRIAL

      Clinical infectious diseases
    89. STEIN DS; HOOVER DR; GRAHAM NMH; CHU C; DETELS R; RIDDLER SA; PHAIR JP; SAAH AJ
      THE EFFECT OF PROPHYLAXIS WITH DAPSONE ON DEVELOPMENT OF MYCOBACTERIUM-AVIUM-INTRACELLULARE DISEASE - AN ANALYSIS OF THE MULTICENTER AIDS COHORT STUDY

      Infectious diseases in clinical practice
    90. BENEDETTI MS; BANI M
      DESIGN OF IN-VITRO STUDIES TO PREDICT IN-VIVO INHIBITORY DRUG-DRUG INTERACTIONS

      Pharmacological research
    91. LOSURDO G; CASTAGNOLA E; CRISTINA E; TASSO L; TOMA P; BUFFA P; GIACCHINO R
      CERVICAL LYMPHADENITIS CAUSED BY NONTUBERCULOUS MYCOBACTERIA IN IMMUNOCOMPETENT CHILDREN - CLINICAL AND THERAPEUTIC EXPERIENCE

      Head & neck
    92. ROUSSEL G; IGUAL J
      CLARITHROMYCIN WITH MINOCYCLINE AND CLOFAZIMINE FOR MYCOBACTERIUM-AVIUM-INTRACELLULARE COMPLEX LUNG-DISEASE IN PATIENTS WITHOUT THE ACQUIRED-IMMUNE-DEFICIENCY-SYNDROME

      The international journal of tuberculosis and lung disease
    93. Chong, CY; Husson, RN
      Lack of acceptance of guidelines for prevention of disseminated Mycobacterium avium complex infection in infants and children infected with human immunodeficiency virus

      PEDIATRIC INFECTIOUS DISEASE JOURNAL
    94. RAMON PM; TILLIELEBLOND I; LABALETTE P; WALLAERT B; TONNEL AB
      UVEITIS, ARTHRALGIA AND PSEUDO-JAUNDICE I N A HIV SERONEGATIVE PATIENT GIVEN RIFABUTIN

      Revue des maladies respiratoires
    95. FOURNIER S; DEPLUS S; JANIER M; POINSIGNON Y; DECAZES JM; MODAI J
      ANTERIOR UVEITIS IN 3 HIV-INFECTED PATIEN TS TREATED WITH ANTIPROTEASE

      La Presse medicale
    96. BURMAN WJ; STONE BL; BROWN BA; WALLACE RJ; BOTTGER EC
      AIDS-RELATED MYCOBACTERIUM-KANSASII INFECTION WITH INITIAL RESISTANCETO CLARITHROMYCIN

      Diagnostic microbiology and infectious disease
    97. FATKENHEUER G; SALZBERGER B; DIEHL V
      DISSEMINATED INFECTION WITH MYCOBACTERIUM -AVIUM COMPLEX IN PATIENTS WITH HIV-INFECTION

      Medizinische Klinik
    98. WRIGHT J
      CURRENT STRATEGIES FOR THE PREVENTION AND TREATMENT OF DISSEMINATED MYCOBACTERIUM-AVIUM COMPLEX INFECTION IN PATIENTS WITH AIDS

      Pharmacotherapy
    99. ALBENGRES E; LELOUET H; TILLEMENT JP
      SYSTEMIC ANTIFUNGAL AGENTS - DRUG-INTERACTIONS OF CLINICAL-SIGNIFICANCE

      Drug safety
    100. FREEDBERG KA; SCHARFSTEIN JA; SEAGE GR; LOSINA E; WEINSTEIN MC; CRAVEN DE; PALTIEL AD
      THE COST-EFFECTIVENESS OF PREVENTING AIDS-RELATED OPPORTUNISTIC INFECTIONS

      JAMA, the journal of the American Medical Association


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 20/10/20 alle ore 14:52:51